The team of Imavita is composed of the following people:
CEO / CSO, founder, DVM. Eric is a veterinarian from the National Veterinary School of Toulouse (ENVT) with a degree in pharmacokinetics / pharmcodynamics. After his thesis, he spent 2 years as Project manager at Hoechst Roussel Vet in Fortaleza, Brazil. From 1999 to 2008, he worked at Avogadro, France as Project Lanager and during the last 4 years as Director of the Biochemistry Laboratory. From 2009 to 2012, he was Chief Scientific Officer of Synelvia. Eric brings his experience of laboratory, animal facilities management and his knowledge in biomarkers development and validation, PK/PD relationships, pre-clinical pathology models and pre-clinical imaging.
CFO, founder. Bernard has an important career in financing of major and small companies in Americas. He brings his knowledge as senior in financing, accountability and strategical development.
PhD, Project Leader. Virginie is a young PhD graduated on 2012. She has spent 4 years at the laboratory of the Center of Cancerology Research of Toulouse (Centre de Recherche en Cancérologie de Toulouse (CRCT) U1037 INSERM / UPS / CNRS) and has worked on the role of sphingosine 1-phosphate in melanoma-stroma interactions.
Neuropharmacologist, PhD, Project Leader, was graduated on 2004 at the l’Institut de Pharmacologie et de Biologie Structurale, CNRS, Toulouse. She has 10 years of experience as head of pharmacology et PharmaLeads, Paris, France. She brings experience in preclinical development, in vivo models in neurology. Elisabeth actually helps in the implementation of new preclinical models in the areas of neurology and dermatology.
MSc, Research Scientist, is graduated from University of Paul Sabatier, Toulouse, France (Master Bioingéniérie 2015). Jeanne works in the in vitro lab and helps in applications of in vivo models for drug efficacy evaluation.
MSc, Research Scientist, is graduated from University of Paul Sabatier, Toulouse, France (Master Toxicologie 2017). Jeanne works in the in vitro lab and helps in applications of in vivo models for drug efficacy evaluation.
The team is completed by external competences (consulting / collaborations) in various fields: